Report
Jonathan Moreland
EUR 9.38 For Business Accounts Only

Daily Insider Ratings Report: July 6, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process
Underlyings
Ominto Inc

Ominto is a global e-commerce company that owns and operates global online shopping and loyalty websites along with a network marketing subsidiary, DubLi Network Limited. Through the company's e-commerce platform, shoppers can browse through different categories of products, which feature international and local brands, travel, coupons, discounts and vouchers and receive cash back on their purchases (Cash Back). The company's Ominto.com website powers and operates the DubLi.com website. The Ominto platform recognizes each customer's preferred shopping locations and delivers a tailored shopping experience.

Precigen Inc

Intrexon is engaged in the field of synthetic biology, focusing on programming biological systems to alleviate disease, remediate environmental challenges, and provide sustainable food and industrial chemicals. Using its suite of technologies, the company designs, builds and regulates gene programs, which are DNA sequences that consist of primary genetic components. A single gene program or a complex, multi-genic program is fabricated and stored within a DNA vector. Vectors are segments of DNA used as a vehicle to transmit genetic information. The company's primary domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Hungary.

Synergy Pharmaceuticals Incorporated

Synergy Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The company is engaged in the discovery, research and development activities around analogs of uroguanylin, a naturally occurring and endogenous human GI peptide, for the treatment of GI diseases and disorders. The company discovered, is developing and controls 100% worldwide rights to its proprietary uroguanylin analog platform. The company's commercial product, plecanatide, under trademark name TRULANCE

Provider
InsiderInsights.com
InsiderInsights.com

Insiderinsights' advanced insider analytics combine statistical track records with numerous behavioral metrics to rate the significance of a firm's insider trading history in real time.

Academic studies and the experience of professionals back the common sense conclusion that the Form 4 data filed daily at the SEC is a profitable data stream to mine for investment intelligence. But most investors use commodity insider feeds that are full of noise and time-consuming to analyze, or ratings services that employ last century's simplistic insider scoring methodology.

InsiderInsights compiles Daily, Weekly, and Monthly reports that list US equities with recent insider activity, along with proprietary Company Ratings clearly indicating the Significance Level of insider sentiment. Our monthly Special Screens further combine our Ratings with various fundamental and price action criteria, to highlight the best value, growth, momentum, and short ideas coming from the executive suite.

Analysts
Jonathan Moreland

Other Reports on these Companies
Other Reports from InsiderInsights.com

ResearchPool Subscriptions

Get the most out of your insights

Get in touch